Neoadjuvant therapy treats cancer before surgery to shrink tumors and test drug response; adjuvant therapy kills leftover cells after surgery. New evidence shows neoadjuvant may be just as effective with fewer side effects, especially for lung and breast cancers.
Jan, 31 2026
